Theravance Biopharma, Inc. (TBPH)
TBPHTheravance Biopharma, Inc.loading…
loading…
QTick signal
+2net
1 bull / 0 bear factors · balancedBull 2 pts·Bear 0 pts30d
loading…
Market context—Sector read · not on file—Balance sheet · not on file—PCE inflation days · not on file—Knife guard · not on file
Chart pattern
—
not on file
Volume vs its own 20-session averagenot on file
52-week range$13.08 – $21.03
Below high since 2015-60.6% · $43.25 high
Risk / reward15.15 : 1
Plan stop$16.77
Max pain—
RSI 1457.9 fires under 35 · fires near $16.84
Forensic flags1 review
Earnings multiple13.4× fwd · 16.4× trailing
P/E vs its own past61st pctile · 0.9× median
Price / booknot on file
Entry strategy · 10 triggers
1 of 6 evaluableRSI 14
●
57.9
fires under 35 · fires near $16.84
vs 50-day
●
—
not on file
Bollinger
●
—
not on file
VWAP 20
●
—
not on file
Entry level
✓
$16.94
within 1% of model level
Put wall
●
—
not on file
MACD
Context●
-0.01
below zero · rising toward the flip
RVolStatic
—
not on file
Short int.Static
6.8%
short interest below 20%
ATRStatic
—
not on file
A checklist, not odds on a return: with only 1 usable price conditions there is nothing to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, RVol, Short int. and ATR are context only — they never count toward the total.
Next earnings
2026-11-10
in 34 sessions
Next dividend
No indicated yield
no forward dividend on file